Gerald P Donovan

Progenics Pharmaceuticals, Inc.

$9,061,908

Attributed

$9,061,908

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.1M · FY2005–10

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

Funding mix

By agency

NIH$9,061,908 · 6

By mechanism

RC4$4,143,652 · 1

R44$3,635,264 · 1

R43$1,282,992 · 4

Top collaborators

No co-investigators on record.

Most similar at Progenics Pharmaceuticals, Inc.

Same institution · by research overlap

Dangshe Ma$5,789,789
William C Olson$17,385,230

Others in their field

Top investigators on “Prostate Specific Antigen”

David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$31,530,718
Peter J. Snyder · University Of Pennsylvania$28,783,628
Larry Arthur$22,516,306
Barbara B O'Brien · Westat, Inc.$20,861,354
Martin G Pomper · Johns Hopkins University$15,781,307

Research focus

Prostate Specific AntigenLaboratory MouseMaleNeoplasm /Cancer ImmunotherapyProstate NeoplasmsMonoclonal AntibodyGenetically Modified AnimalsSuccessInnovationNeoplasm /Cancer VaccineVaccine DevelopmentImmunologic Substance Development /PreparationVector VaccinePharmacologic SubstancePreventAnimal ModelCessation Of LifeInvestigational New Drug ApplicationInsightIn VivoAnimalsIncidenceAntitumor AntibodyImmune